The course of COVID-19 in patients with severe asthma receiving biological treatment
Author:
Affiliation:
1. Faculty of Medicine, Division of Allergy and Clinical Immunology, Hacettepe University, Ankara, Turkey
Publisher
Informa UK Limited
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health
Link
https://www.tandfonline.com/doi/pdf/10.1080/02770903.2021.1996599
Reference21 articles.
1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
2. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
3. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
4. Effect of asthma and asthma medication on the prognosis of patients with COVID-19
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis;Journal of Infection and Public Health;2023-05
2. The effect of COVID-19 on patients recieving omalizumab treatment;Revue Française d'Allergologie;2023-03
3. Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience;Tuberk Toraks;2022-09-26
4. Viral Infection and Airway Epithelial Immunity in Asthma;International Journal of Molecular Sciences;2022-08-31
5. Asthma and COVID-19 Associations: Focus on IgE-Related Immune Pathology;Life;2022-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3